2015
DOI: 10.1136/bjophthalmol-2015-307012
|View full text |Cite
|
Sign up to set email alerts
|

Optic neuropathy in late-onset neurodegenerative Chédiak–Higashi syndrome

Abstract: This report expands the ophthalmological phenotype of the late-onset neurodegenerative form of CHS to include optic neuropathy with progressive vision loss, even in the absence of ocular albinism, and abnormal prominence of the interdigitation zone between cone outer segment tips and apical processes of retinal pigment epithelium cells on macular OCT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…It is characterised by iris transillumination, foveal hypoplasia, chiasmal misrouting on visual-evoked potentials (VEPs) and variably reduced pigmentation of the fundus, hair and skin. OCA is a feature of certain syndromes including Hermansky–Pudlak syndrome (HPS, MIM#203300) associated with bleeding diathesis, pulmonary fibrosis and granulomatous colitis and Chediak–Higashi syndrome (MIM#214500) with immunodeficiency and neurological involvement 2 3…”
Section: Introductionmentioning
confidence: 99%
“…It is characterised by iris transillumination, foveal hypoplasia, chiasmal misrouting on visual-evoked potentials (VEPs) and variably reduced pigmentation of the fundus, hair and skin. OCA is a feature of certain syndromes including Hermansky–Pudlak syndrome (HPS, MIM#203300) associated with bleeding diathesis, pulmonary fibrosis and granulomatous colitis and Chediak–Higashi syndrome (MIM#214500) with immunodeficiency and neurological involvement 2 3…”
Section: Introductionmentioning
confidence: 99%
“…Clinically, patients may present with photophobia, nystagmus, and changes in visual acuity [1,6]. Vision loss may be progressive [8,9].…”
Section: Clinical Manifestationsmentioning
confidence: 99%